Drugs / QIV
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05886777 | Jun 2023 → Jan 2024 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05886777 ↗ |
| Modality | Vaccine | “quadrivalent influenza vaccine (QIV)” NCT05886777 ↗ |
| Route | Intramuscular | “Licensed QIV given as an intramuscular injection” NCT05886777 ↗ |